Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Clinical trial NCT03859388 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03859388
Sponsor: Cedars-Sinai Medical Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Rejection Chronic Renal Kidney Transplant Rejection

Start date: 2019-03-01
Primary completion: 2025-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.